Novartis AG — Director's Dealing 2011

Dec 9, 2011

SEC Form 4/A — Form 4/A

Issuer: IDENIX PHARMACEUTICALS INC (IDIX)
CIK: 0001093649
Period of Report: 2011-11-22

Reporting Person: NOVARTIS AG (Indirect 10% Owner)
Reporting Person: NOVARTIS PHARMA AG (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-11-22	Common Stock	P	6476	$2.96	Acquired	33202903	Indirect
2011-11-22	Common Stock	P	20288	$4.70	Acquired	33224477	Indirect

Footnotes

F1: Price is corrected from $2.95 to $2.96.

F2: These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities. See attachment.

F3: The amount of securities acquired is corrected from 20,228 to 20,288.